Article
Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.
PloS one - 1 Jan 2012
Drew Damien R, Hodder Anthony N, Wilson Danny W, Foley Michael, Mueller Ivo, Siba Peter M, Dent Arlene E, Cowman Alan F, Beeson James G
Abstract excerpt
Apical Membrane Antigen 1 (AMA1) is a leading malaria vaccine candidate and a target of naturally-acquired human immunity. Plasmodium falciparum AMA1 is polymorphic and in vaccine trials it induces strain-specific protection. This antigenic diversity is a major roadblock to development of AMA1 as a malaria vaccine and understanding how to overcome it is essential. To assess how AMA1 antigenic diversity limits...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
